Oncological role of HMGA2 (Review)

  • Authors:
    • Shizhen Zhang
    • Qiuping Mo
    • Xiaochen Wang
  • View Affiliations

  • Published online on: August 13, 2019     https://doi.org/10.3892/ijo.2019.4856
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The high mobility group A2 (HMGA2) protein is a non‑histone architectural transcription factor that modulates the transcription of several genes by binding to AT‑rich sequences in the minor groove of B‑form DNA and alters the chromatin structure. As a result, HMGA2 influences a variety of biological processes, including the cell cycle process, DNA damage repair process, apoptosis, senescence, epithelial‑mesenchymal transition and telomere restoration. In addition, the overexpression of HMGA2 is a feature of malignancy, and its elevated expression in human cancer predicts the efficacy of certain chemotherapeutic agents. Accumulating evidence has suggested that the detection of HMGA2 can be used as a routine procedure in clinical tumour analysis.

Related Articles

Journal Cover

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Zhang, S., Mo, Q., & Wang, X. (1899). Oncological role of HMGA2 (Review). International Journal of Oncology, 0, 0-0. https://doi.org/10.3892/ijo.2019.4856
MLA
Zhang, S., Mo, Q., Wang, X."Oncological role of HMGA2 (Review)". International Journal of Oncology 0.0 (1899): 0-0.
Chicago
Zhang, S., Mo, Q., Wang, X."Oncological role of HMGA2 (Review)". International Journal of Oncology 0, no. 0 (1899): 0-0. https://doi.org/10.3892/ijo.2019.4856